Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Star Scientific, Inc.

Market Cap 153K 132K 122K 115K 215K 14.48M 217K 1.44M 561K 7.11M 576K 563K 24.58M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.26M 15.87M 14.94M 28.07M 1.89B 28.31M 188M 73.23M 927M 75.1M 73.5M 3.21B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%-2.14%+40.54%+148.38% 992B
-0.42%-1.80%+53.69%+42.60% 564B
-0.56%-1.65%+19.27%+59.57% 391B
-0.40%+0.68%+24.66%+16.53% 330B
-0.40%-1.22%+27.15%+15.16% 280B
-0.55%-1.02%+26.67%+32.42% 279B
-0.75%-0.02%-41.45%-47.82% 196B
-1.78%+1.16%+17.79%+48.77% 184B
-1.40%+3.27%+16.16%+59.08% 156B
Average -0.27%+0.41%+20.50%+41.63% 374.58B
Weighted average by Cap. -0.08%-0.49%+29.32%+65.85%

Financials

2014 2015
Net sales - -
Net income -38.52M -33.23M -30.55M -28.75M -54.03M -3.64B -54.49M -362M -141M -1.78B -145M -141M -6.17B -6.84M -5.91M -5.43M -5.11M -9.6M -646M -9.68M -64.34M -25.05M -317M -25.69M -25.14M -1.1B
Net Debt -45K -38.82K -35.69K -33.59K -63.13K -4.25M -63.66K -423K -165K -2.08M -169K -165K -7.21M 19.86M 17.13M 15.75M 14.82M 27.86M 1.87B 28.09M 187M 72.66M 920M 74.53M 72.93M 3.18B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!